Evidence suggests the gene NFKB could be a genetic pathway for amplifying inflammation in sepsis, a leading cause of hospital deaths.
Researchers used blood from human subjects and found patients with a specific genetic variation had an increase in the gene after infection. The study could determine if anti-inflammatory sepsis treatment should be tailored for patients with certain genetic sequences.
More Articles on Anesthesia:
What Does the Future Hold for Ambulatory Anesthesia? Q&A With SAMBA’s Dr. Michael Walsh
CMS Braces for 27% Mandated Sustainable Growth Rate Cut in 2013
Proposed Legislation Could Ease Anesthesia Participation in Meaningful Use
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
